"Burkitt Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
- Burkitt Lymphoma
- Burkitt Leukemia
- Leukemia, Burkitt
- Leukemia, Lymphoblastic, Burkitt-Type
- Burkitt's Lymphoma
- Burkitts Lymphoma
- Lymphoma, Burkitt's
- Burkitt Cell Leukemia
- Cell Leukemia, Burkitt
- Leukemia, Burkitt Cell
- Burkitt's Tumor
- Burkitts Tumor
- Tumor, Burkitt's
- Burkitt Tumor
- Tumor, Burkitt
- Leukemia, Lymphocytic, L3
- Lymphocytic Leukemia, L3
- L3 Lymphocytic Leukemia
- L3 Lymphocytic Leukemias
- Leukemia, L3 Lymphocytic
- Leukemias, L3 Lymphocytic
- Lymphocytic Leukemias, L3
- Burkitt's Leukemia
- Burkitts Leukemia
- Leukemia, Burkitt's
- Lymphoma, Burkitt
Below are MeSH descriptors whose meaning is more general than "Burkitt Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Burkitt Lymphoma".
This graph shows the total number of publications written about "Burkitt Lymphoma" by people in this website by year, and whether "Burkitt Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Burkitt Lymphoma" by people in Profiles.
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy. Clin Cancer Res. 2017 Aug 01; 23(15):4212-4223.
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma. Cancer. 2016 Feb 15; 122(4):559-64.
Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leuk Lymphoma. 2016; 57(4):866-71.
Cloaked in a starry sky. Blood. 2014 Apr 10; 123(15):2291.
The identity crisis of Kr?ppel-like factor 4. Leuk Lymphoma. 2014 Aug; 55(8):1703-4.
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10?002. Br J Haematol. 2014 Apr; 165(1):102-11.
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma. Ann Oncol. 2013 Dec; 24(12):3076-81.
Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma. Mol Cancer Res. 2013 Jun; 11(6):604-15.
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest. 2012 Dec; 122(12):4621-34.
Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib. Hematol Oncol. 2013 Sep; 31(3):164-6.